Advertisement

Topics

Meningococcal Conjugates Vaccine - Biotech, Pharma and Life Science Channel

12:24 EST 21st January 2017 | BioPortfolio

PubMed Articles [1686 Associated PubMed Articles listed on BioPortfolio]

Two approaches to the use of benzoc1,2oxaboroles as active fragments for synthetic transformation of clarithromycin().

Clarithromycin (active against Gram positive infections) and 1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole derivatives (effective for Gram negative microbes) are the ligands of bacterial RNA. The antimi...

Vaccine Candidates against Nontypeable Haemophilus influenzae: a Review

Nonencapsulated, nontypeable Hemophilus influenzae (NTHi) remains an important cause of acute otitis and respiratory diseases in children and adults. NTHi bacteria are one of the major causes of respi...

Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.

Trastuzumab-MCC-DM1 (T-DM1) is an antibody-drug conjugate (ADC) that consists of a monoclonal antibody (mAb) trastuzumab non-cleavably linked to a cytotoxic drug DM1. During production, the DM1 agents...

Reaction of zearalenone and α-zearalenol with allyl isothiocyanate, characterization of reaction products, their bioaccessibility and bioavailability in vitro.

This study investigates the reduction of zearalenone (ZEA) and α-zearalenol (α-ZOL) on a solution model using allyl isothiocyanate (AITC) and also determines the bioaccessibility and bioavailability...

A Survey of Parental Perception and Pattern of Action in Response to Influenza-like Illness in Their Children: Including Healthcare Use and Vaccination in Korea.

Seasonal influenza is a significant cause of morbidity and mortality of children in Korea. However, few data are available on parental perception and action toward childhood influenza. This study aime...

Proteomics: Technologies and Their Applications.

Proteomics involves the applications of technologies for the identification and quantification of overall proteins present content of a cell, tissue or an organism. It supplements the other "omics" ...

Zika Virus Molecular Biology and Perspectives for Vaccine Development: A Review.

Nicolau syndrome induced by intramuscular injection of a hexavalent vaccine in a 6-month-old girl.

Nicolau syndrome, also known as embolia cutis medicamentosa or livedo-like dermatitis, is a sudden tissue necrosis, a rare complication of intramuscular injection of some drugs. We report a case of a ...

Coverage with Tetanus, Diphtheria, and Acellular Pertussis Vaccine and Influenza Vaccine Among Pregnant Women - Minnesota, March 2013-December 2014.

Pertussis and influenza infections can result in severe disease in infants. The diphtheria, tetanus, acellular pertussis (DTaP) vaccine is recommended for infants beginning at age 2 months, and influe...

Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant.

Lack of safe and effective adjuvants is a major hindrance to the development of efficacious vaccines. Signaling via CD40 pathway leads to enhanced antigen processing and presentation, nitric oxide exp...

News Articles [2370 Associated News Articles listed on BioPortfolio]

Best Ways to Steer Clear of the Flu

SATURDAY, Jan. 21, 2017 -- The best way for people to protect themselves from the flu is to get vaccinated -- and it's not too late to get a shot, an infectious diseases expert says. The flu vaccine a...

Team Uncovers Cellular Responses to Avian Influenza Vaccine

New research from Vanderbilt eavesdrops on gene expression in human immune system cells before and after vaccination against bird flu. Reported in the journal PLOS One, the study exposes cellular resp...

This Week in Zika: Global Org to Address Vaccine Development

(MedPage Today) -- Also, research into antiviral therapies continued

Abzena shares up 65% after US$300mln licensing deal

Shares in Abzena plc (AIM:ABZA) rocketed 65% after it said it had signed an agreement with an unnamed a San Diego biopharmaceutical company worth up to US$300mln to license out its ThioBridge technolo...

Genital Herpes Vaccine Candidate Has Promising Results in Preclinical Tests

NewsNew genital herpes vaccine candidate provides powerful protection in preclinical tests.

Human medicines European public assessment report (EPAR): Vepacel, Prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture), Revision: 7, Authorised

Vaccine exemptions are on the rise in a number of US states

Non-medical vaccine exemptions are rising in certain states, including ones that haven't previously been considered hotbeds of anti-vaccination sentiment.

Abzena agrees US licensing deal worth up to US$300mln

Abzena plc (AIM:ABZA) has signed an agreement with an unnamed a San Diego-based biopharmaceutical company worth up to US$300mln to license out its ThioBridge technology. ThioBridge is an antibody dr...

BioDiem Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryBioDiem Ltd BioDiem is a biotechnology company which focuses on developing and commercializing vaccines and infectious disease therapies. The company develops vaccines and novel therapeutic can...

Deals this week: Shenzhen Kangtai Biological Products, Telix Pharmaceuticals, Fresenius Finance Ireland

Chinese vaccine and biologic products developer and manufacturer Shenzhen Kangtai Biological Products has announced the pricing for an initial public offering (IPO) of shares to raise ¥138.2m ($20.08...

Events [0 Results]

None

Companies [109 Associated Companies listed on BioPortfolio]

IDT Biologika and CMC Biologics

IDT Biologika is an innovative life science company headquartered in Dessau, Germany with extensive expertise in research, development and manufacturing of vaccines, and in additi...

SynAffix

SynAffix is a protein engineering company located in Oss (the Netherlands), focused on the development of next-generation Antibody-Drug Conjugates (ADCs) for targeted cancer and other diseases. SynA...

TOMTEC

Tomtec has succeeded since 1967 by working with its clients to help solve their liquid handling needs. From 1967 to 1981, the Company had essentially one employee, Tom Astle. From 1967 to 1971, the Co...

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics is an Oxford, UK-based development stage biotechnology company with a particular focus on immune therapeutics in oncology. PsiOxus has developed a pate...

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allo...

VaxAlta Inc.

VaxAlta is a leading glycoconjugate vaccine research and development company based in Edmonton, Alberta. Founded in 2013, the company is focused on developing sugar-based, effecti...

IDT Biologika

IDT Biologika is an innovative, privately-held life science company with more than 94 years history and expertise in Research, Development and Manufacturing of biologics for the g...

ImmusanT, Inc.

ImmusanT is a privately held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented ...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides control...

Clinical Trials [2815 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age

The trial is a phase III, non-inferiority, observer-blind, randomised, active controlled, multicentre clinical trial with 2 parallel groups: IPV-Al SSI (investigational vaccine) and IPV SS...

Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)

The purpose of the study is to investigate and compare the human immune response in epithelial cells of the nasopharyngeal mucosa and in blood to live, attenuated influenza vaccine (LAIV) ...

HPV Antibody Response After GARDASIL 9 Vaccination in Participants After Allogeneic Stem Cell Transplantation

The goal of this clinical research study is to learn if Gardasil (the HPV vaccine) can prevent HPV infection and HPV-related disease when given to blood cancer patients who have received a...

The Human Mucosal Immune Responses to Influenza Virus (SLVP026)

This study will examine the immune responses to the seasonal influenza vaccine in single cells of the nasal passages when compared with cells in circulating blood.

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012

This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011

This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.

Low Birth Weight Follow-up

The Randomized Control Trail included 4,172 low-birth weight children between February 2008 and September 2013 in Bissau. The children who were included in the RCT and who are living in th...

Kinetics of B-Cell Responses to Live Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age

This pilot study will investigate the peak of the post-immunization B-cell responses following vaccination with live, attenuated influenza vaccine in healthy children 2 years of age from b...

B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)

In this exploratory study, investigators will be looking at immune response differences between age groups and between the two different influenza vaccines given to identical twins and vac...

Videos

None available.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)

Quick Search
Advertisement
 
review and buy Meningococcal Conjugates Vaccine market research data and corporate reports here

Channels Quicklinks